Summary
Boston Scientific Corporation (BSX) filed an 8-K on January 20, 2017, reporting the upcoming departure of a key board member, Dr. Kristina M. Johnson. Dr. Johnson, who has a long-standing history with the company's board, has decided not to seek re-election at the 2017 Annual Meeting. She currently holds significant positions as the Chairman of the Executive Compensation and Human Resources Committee and as a member of the Finance Committee. This departure, while noted, is explicitly stated to be without any disagreement with the Company, which should provide some comfort to investors. Dr. Johnson will continue in her current roles and as a director until the 2017 Annual Meeting, ensuring a smooth transition. Investors should monitor any announcements regarding her replacement and the potential impact on board composition and committee leadership.
Key Highlights
- 1Dr. Kristina M. Johnson will not stand for re-election to the Board of Directors at the 2017 Annual Meeting.
- 2Dr. Johnson has served on the Board of Directors since January 2011 and previously from April 2006 to May 2009.
- 3She currently chairs the Executive Compensation and Human Resources Committee.
- 4Dr. Johnson is also a member of the Finance Committee.
- 5Her decision not to seek re-election is not due to any disagreement with the Company.
- 6Dr. Johnson will continue to serve as a director and in her committee roles until the 2017 Annual Meeting.